Simtek Medico Systems Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 26-05-2024
- Paid Up Capital ₹ 0.79 M
as on 26-05-2024
- Company Age 21 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 37.01%
(FY 2022)
- Profit 149.77%
(FY 2022)
- Ebitda 27.81%
(FY 2022)
- Net Worth 12.23%
(FY 2022)
- Total Assets 11.09%
(FY 2022)
About Simtek Medico Systems
The Company is engaged in the Electrical Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.79 M, as per Ministry of Corporate Affairs (MCA) records.
Milan Shah, Bina Shah, and Lopa Vinchhi serve as directors at the Company.
- CIN/LLPIN
U33125MH2003PTC140506
- Company No.
140506
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 May 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Simtek Medico Systems Private Limited offer?
Simtek Medico Systems Private Limited offers a wide range of products and services, including Surgical & ICU Equipments, Medical Pumps, Syringe Pump, Infusion Pumps.
Who are the key members and board of directors at Simtek Medico Systems?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Milan Shah  | Additional Director | 12-Jun-2023 | Current |
| Bina Shah | Director | 21-May-2003 | Current |
| Lopa Vinchhi | Additional Director | 04-Apr-2019 | Current |
Financial Performance of Simtek Medico Systems.
Simtek Medico Systems Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 37.01% increase. The company also saw a substantial improvement in profitability, with a 149.77% increase in profit. The company's net worth Soared by an impressive increase of 12.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Simtek Medico Systems?
In 2016, Simtek Medico Systems had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Prachi Trading And Commercial Private LimitedActive 33 years 8 monthsMilan Shah and Bina Shah are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Simtek Medico Systems?
Unlock and access historical data on people associated with Simtek Medico Systems, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Simtek Medico Systems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Simtek Medico Systems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
